Haleon PLC shares fall 1.38% and underperform broader market

16 articles · Updated · MarketWatch · Apr 27

Haleon PLC closed at £3.50 on Monday, with trading volume at 11.2 million, below its 50-day average of 22.8 million.
The stock ended 16.50% below its 52-week high of £4.20, reached on May 30th last year.
The decline occurred during a generally rough trading session, as the FTSE 100 Index also dropped 0.56% to 10,321.09.

Haleon's stock fell despite strong profits. Is this a market overreaction or a sign of deeper issues?

Will Haleon’s new strategy be enough to finally reach its ambitious 4-6% growth target?

How does a public health success like a mild flu season become a financial problem for a health company?

Can Haleon's new cost-saving strategy offset cautious consumer spending in North America?

With a weak flu season hurting sales, how will Haleon innovate its brands to reduce seasonal dependency?